News
2d
Zacks Investment Research on MSN3 Reasons Growth Investors Will Love ANI (ANIP)Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a growth stock that ...
4d
Zacks Investment Research on MSNAre Medical Stocks Lagging ANI Pharmaceuticals (ANIP) This Year?The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is ANI Pharmaceuticals (ANIP) one of those stocks right now? A ...
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Geron (GERN – Research Report), Genmab (GMAB – Research ...
Truist analyst Les Sulewski raised the firm’s price target on ANI Pharmaceuticals (ANIP) to $65 from $62 and keeps a Hold rating on the shares ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results